NAUTILUS BIOTECHNOLOGY INC Share Price Today: Live Updates & Key Insights

NAUTILUS BIOTECHNOLOGY INC share price today is $3.02, up 10.18%. The stock opened at $2.83 against the previous close of $2.75, with an intraday high of $3.055 and low of $2.74.

NAUTILUS BIOTECHNOLOGY INC Share Price Chart

NAUTILUS BIOTECHNOLOGY INC

us-stock
To Invest in {{usstockname}}
us-stock

NAUTILUS BIOTECHNOLOGY INC Share Price Performance

$3.02 0.1018(10.18%) NAUT at 23 Mar 2026 02:25 PM Biotechnology
Lowest Today 2.74
Highest Today 3.055
Today’s Open 2.83
Prev. Close 2.75
52 Week High 3.08
52 Week Low 0.62
Day’s Range: Low 2.74 High 3.055
52-Week Range: Low 0.62 High 3.08
1 day return -
1 Week return +27.31
1 month return +12.22
3 month return +53.41
6 month return +326.76
1 year return +205.07
3 year return +20.71
5 year return -77.7
10 year return -

NAUTILUS BIOTECHNOLOGY INC Institutional Holdings

Perceptive Advisors LLC 9.95

Cercano Management LLC 5.67

Madrona Venture Group, LLC 4.76

Vanguard Group Inc 2.05

Comprehensive Financial Management LLC 1.74

Vanguard Total Stock Mkt Idx Inv 1.42

Amazon.com Inc 1.15

Clarius Group, LLC 0.96

Millennium Management LLC 0.81

Sentinel Trust CO Lba 0.59

Tikvah Management LLC 0.57

Geode Capital Management, LLC 0.44

Vanguard Institutional Extnd Mkt Idx Tr 0.38

CI Private Wealth LLC 0.25

Dimensional Fund Advisors, Inc. 0.23

Renaissance Technologies Corp 0.21

Alyeska Investment Group, L.P. 0.20

Fidelity Extended Market Index 0.20

Acadian Asset Management LLC 0.19

Jane Street Group LLC 0.16

BlackRock Inc 0.16

Hillman Co 0.16

State Street Corp 0.14

Bridgeway Ultra-Small Company Market 0.10

Blackrock Extended Mkt Fund CF 0.08

Extended Equity Market Fund K 0.07

Fidelity Total Market Index 0.06

Dimensional US Core Equity 2 ETF 0.06

Fidelity Nasdaq Composite Index 0.05

DFA US Small Cap I 0.05

Fidelity Series Total Market Index 0.05

Goldman Sachs Absolute Ret Trckr Instl 0.05

Spartan Extended Market Index Pool F 0.05

Vanguard Instl Ttl Stck Mkt Idx Tr 0.05

Northern Trust Extended Eq Market Idx 0.04

NT Ext Equity Mkt Idx Fd - L 0.04

NT Ext Equity Mkt Idx Fd - NL 0.04

Vanguard Instl Ttl Stk Mkt Idx InstlPls 0.04

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.03

Dimensional US Small Cap ETF 0.03

NAUTILUS BIOTECHNOLOGY INC Market Status

Strong Buy: 2

Buy: 0

Hold: 2

Sell: 0

Strong Sell: 0

NAUTILUS BIOTECHNOLOGY INC Fundamentals

Market Cap 383.49 M

PB Ratio 2.443

PE Ratio 0.0

Enterprise Value 310.10 M

Total Assets 191.11 M

Volume 500454

NAUTILUS BIOTECHNOLOGY INC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:null 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-60060000 -60.1M, FY22:-63740000 -63.7M, FY21:-50315000 -50.3M, FY20:-15619000 -15.6M, FY19:2578622 2.6M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-1619000 -1.6M, Q2/2025:-1633000 -1.6M, Q1/2025:-1625000 -1.6M, Q3/2024:-1612000 -1.6M, Q2/2024:-1597000 -1.6M

Quarterly Net worth Q3/2025:-13574000 -13.6M, Q2/2025:-15033000 -15.0M, Q1/2025:-16613000 -16.6M, Q3/2024:-16446000 -16.4M, Q2/2024:-18010000 -18.0M

About NAUTILUS BIOTECHNOLOGY INC & investment objective

Company Information Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers single-molecule library preparation kits, flow cells, affinity reagents, and instrument run buffers to perform multi-cycle analysis runs. It has a research collaboration agreement Genentech, Buck Institute, Allen Institute, Cornell University and the Qatar Foundation, and Michael J. Fox Foundation. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.

Organisation Biotechnology

Employees 130

Industry Biotechnology

CEO Mr. Sujal M. Patel

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

NAUTILUS BIOTECHNOLOGY INC FAQs

What is the share price of NAUTILUS BIOTECHNOLOGY INC today?

The current share price of NAUTILUS BIOTECHNOLOGY INC is $3.02.

Can I buy NAUTILUS BIOTECHNOLOGY INC shares in India?

Yes, Indian investors can buy NAUTILUS BIOTECHNOLOGY INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy NAUTILUS BIOTECHNOLOGY INC shares in India?

You can easily invest in NAUTILUS BIOTECHNOLOGY INC shares from India by:

Can I buy fractional shares of NAUTILUS BIOTECHNOLOGY INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of NAUTILUS BIOTECHNOLOGY INC?

NAUTILUS BIOTECHNOLOGY INC has a market cap of $383.49 M.

In which sector does NAUTILUS BIOTECHNOLOGY INC belong?

NAUTILUS BIOTECHNOLOGY INC operates in the Biotechnology sector.

What documents are required to invest in NAUTILUS BIOTECHNOLOGY INC stocks?

To invest, you typically need:

What is the PE and PB ratio of NAUTILUS BIOTECHNOLOGY INC?

The PE ratio of NAUTILUS BIOTECHNOLOGY INC is N/A and the PB ratio is 2.44.